24 May 2013
Keywords: icahn, pushing, lilly, buy, amylin, latest, move
Article | 21 April 2009
The latest move in the escalating proxy battle with billionaire investor Carl Icahn saw US biotechnology firm Amylin accusing him ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.